Topic Highlight
Copyright ©2010 Baishideng Publishing Group Co.
World J Stem Cells. Aug 26, 2010; 2(4): 81-92
Published online Aug 26, 2010. doi: 10.4252/wjsc.v2.i4.81
Table 2 Current clinical trials listed at http://www.clinicaltrials.gov (research August 2010) employing mesenchymal stromal cells from umbilical cord blood, umbilical cord or placenta or case studies applying mesenchymal stromal cells from perinatal sources
UCB-MSCsSafety and efficacy study of umbilical cord blood-derived mesenchymal stem cells to promote engraftment of unrelated hematopoietic stem cell transplantation
UCB-MSCsSafety and efficacy study of umbilical cord/placenta-derived mesenchymal stem cells to treat myelodysplastic syndromes
UCB-MSCsStem cell therapy for type 1 diabetes mellitus
UCB-MSCsStudy to compare the efficacy and safety of cartistem® and microfracture in patients with knee articular cartilage injury or defect
UC-MSCsA research study looking at specific tissue of the umbilical cord
UC-MSCsAllogeneic mesenchymal stem cell for Graft-versus-host disease treatment
UC-MSCs/Placenta-MSCsSafety and efficacy study of umbilical cord/placenta-derived mesenchymal stem cells to treat myelodysplastic syndromes
Placenta-MSCsSafety of intramuscular injection of Allogeneic PLX-PAD cells for the treatment of critical limb ischemia
UCB-MSCsSuccessful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model[103]
UCB-MSCsA 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study[104]